Cyclophilin A, TRIM5, and Resistance to Human Immunodeficiency Virus Type 1 Infection
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Upon entry of a retrovirus into the cytoplasm of a permissive cell, a viral protein, reverse transcriptase, generates cDNA using viral genomic RNA as template.In a subsequent but also essential step in the retroviral replication cycle, the nascent viral cDNA is ligated to chromosomal DNA by another viral protein, integrase, establishing the provirus.Retroviral infection is thus mutagenic to the host.One highly publicized illustration of the potential for retroviruses to disrupt host gene expression involved activation of the LMO2 proto-oncogene by proximal integration of a vector in a gene therapy trial for X-linked severe combined immunodeficiency (33).Aside from altering host gene expression, retroviruses such as human immunodeficiency virus type 1 (HIV-1) may cause pathology by transducing toxic genes (24).In addition to the genes encoding structural proteins and enzymes, which are themselves toxic to host cells, HIV-1 possesses six accessory genes that exhibit wide-ranging effects on cell physiology.Despite immune responses that decrease HIV-1 viremia after acute infection and appear to limit viral pathology for a decade, HIV-1 ultimately kills the host, most likely via complex effects involving all nine of the transduced viral genes.Given the potent effects of retrotransposition on biology and evolution, it is not hard to imagine that susceptible host organisms would elaborate factors that block reverse transcription or any of the steps that lead to integration.Several such factors have been identified and have been discussed previously in a comprehensive fashion (7,31).This review will focus on how, in the course of efforts to identify retroviral inhibitory factors, cyclophilin A (CypA) was discovered to be an HIV-1 CA-binding protein.It will then describe how the characterization of the HIV-1 CA-CypA interaction revealed TRIM5 to be a potent antiretroviral restriction factor.Finally, it will present our current understanding of the mechanism of retroviral inhibition by TRIM5 and explain how CypA modulates retroviral restriction activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tripartite motif family identifies cell compartments
Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., Zanaria, E., Messali, S., Cainarca, S., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2140 · Cited by 1,366 · cited 1×
“TRIM5 is a member of the very large tripartite motif family of proteins ( 70 family members) that is defined by the presence of RING finger, B-box, and coiled-coil domains (57, 65).”
BackgroundTRIM family proteins: retroviral restriction and antiviral defence
Nisole, S., Stoye, J. P., & Saïb, A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1248 · Cited by 761
Specific incorporation of cyclophilin A into HIV-1 virions
Franke, E. K., Yuan, H. E. H., & Luban, J. (1994) · Nature · doi:10.1038/372359a0 · Cited by 745
Self-citationCrystal Structure of Human Cyclophilin A Bound to the Amino-Terminal Domain of HIV-1 Capsid
Gamble, T. R., Vajdos, F. F., Yoo, S., Worthylake, D. K., Houseweart, M., Sundquist, W. I., & Hill, C. P. (1996) · Cell · doi:10.1016/s0092-8674(00)81823-1 · Cited by 706 · cited 2×
“CypA binding is enhanced by CA multimerization (14, 17), though binding to monomeric CA can be detected at high protein concentrations (29).”
BackgroundSawyer, S. L., Wu, L. I., Emerman, M., & Malik, H. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409853102 · Cited by 688
Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1
Sayah, D. M., Sokolskaja, E., Berthoux, L., & Luban, J. (2004) · Nature · doi:10.1038/nature02777 · Cited by 662 · cited 7×
“Competitive inhibitors and genetic modifications that block the HIV-1 CA-CypA interaction were shown to decrease HIV-1 sensitivity to restriction activity in simian cells (3, 4, 47, 70, 87).”
BackgroundInfluentialSelf-citationStructure of the Amino-Terminal Core Domain of the HIV-1 Capsid Protein
Gitti, R. K., Lee, B. M., Walker, J., Summers, M. F., Yoo, S., & Sundquist, W. I. (1996) · Science · doi:10.1126/science.273.5272.231 · Cited by 459
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication
König, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M. C., Irelan, J. T., Chiang, C.-Y., Tu, B. P., De Jesus, P. D., Lilley, C. E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.032 · Cited by 960
HIV-1 assembly, budding, and maturation
Sundquist, W. I., & Krausslich, H.-G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006924 · Cited by 814
“In newly infected cells, the capsid interacts with both positive-acting host factors like cyclophilin A and transportin-3, and with restriction factors of the TRIM5-a family (Luban 2007; Sebastian and Luban 2007; Yamashita and Emerman 2009; Krishnan et al. 2010).”
BackgroundTRIM5 is an innate immune sensor for the retrovirus capsid lattice
Pertel, T., Hausmann, S., Morger, D., Züger, S., Guerra, J., Lascano, J., Reinhard, C., Santoni, F. A., Uchil, P. D., Chatel, L., et al. (2011) · Nature · doi:10.1038/nature09976 · Cited by 645
Self-citationHIV-1 capsid: the multifaceted key player in HIV-1 infection
Campbell, E. M., & Hope, T. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3503 · Cited by 430
Metadata
- Authors
- Luban, J.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2007-02
- Volume
- 81
- Issue
- 3
- Pages
- 1054-1061
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2152550969
- Cited by
- 147
- References
- 7
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.